Interview with Andrew Zelenetz, MD, PhD, Medical Oncology Memorial Sloan Kettering Cancer Center
From the 14th annual International Workshop on Non-Hodgkin Lymphoma, Dr. Andrew Zelenetz was first interviewed about how it is absolutely critical to receive an accurate diagnosis. He shares that about 17% – 20% of diagnoses change in a way that effect the therapy chosen. Next, he explains some of the exciting new drugs being used to combat NHL. Watch the full videos below to hear from a NHL expert.